Literature DB >> 26655199

Comparative evaluation of PCR amplification of RLEP, 16S rRNA, rpoT and Sod A gene targets for detection of M. leprae DNA from clinical and environmental samples.

Ravindra P Turankar1, Shradha Pandey1, Mallika Lavania1, Itu Singh1, Astha Nigam1, Joydeepa Darlong1, Fam Darlong1, Utpal Sengupta2.   

Abstract

PURPOSE: PCR assay is a highly sensitive, specific and reliable diagnostic tool for the identification of pathogens in many infectious diseases. Genome sequencing Mycobacterium leprae revealed several gene targets that could be used for the detection of DNA from clinical and environmental samples. The PCR sensitivity of particular gene targets for specific clinical and environmental isolates has not yet been established. The present study was conducted to compare the sensitivity of RLEP, rpoT, Sod A and 16S rRNA gene targets in the detection of M. leprae in slit skin smear (SSS), blood, soil samples of leprosy patients and their surroundings.
METHOD: Leprosy patients were classified into Paucibacillary (PB) and Multibacillary (MB) types. Ziehl-Neelsen (ZN) staining method for all the SSS samples and Bacteriological Index (BI) was calculated for all patients. Standard laboratory protocol was used for DNA extraction from SSS, blood and soil samples. PCR technique was performed for the detection of M. leprae DNA from all the above-mentioned samples.
RESULTS: RLEP gene target was able to detect the presence of M. leprae in 83% of SSS, 100% of blood samples and in 36% of soil samples and was noted to be the best out of all other gene targets (rpoT, Sod A and 16S rRNA). It was noted that the RLEP gene target was able to detect the highest number (53%) of BI-negative leprosy patients amongst all the gene targets used in this study.
CONCLUSION: Amongst all the gene targets used in this study, PCR positivity using RLEP gene target was the highest in all the clinical and environmental samples. Further, the RLEP gene target was able to detect 53% of blood samples as positive in BI-negative leprosy cases indicating its future standardization and use for diagnostic purposes.
Copyright © 2015 Asian African Society for Mycobacteriology. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Clinical samples; Comparison of PCR positivity; Diagnostic of leprosy; Environmental samples; Leprosy and different gene target; M. leprae

Mesh:

Substances:

Year:  2015        PMID: 26655199     DOI: 10.1016/j.ijmyco.2014.11.062

Source DB:  PubMed          Journal:  Int J Mycobacteriol        ISSN: 2212-5531


  13 in total

Review 1.  Leprosy in Children.

Authors:  Josafá Gonçalves Barreto; Marco Andrey Cipriani Frade; Fred Bernardes Filho; Moises Batista da Silva; John Stewart Spencer; Claudio Guedes Salgado
Journal:  Curr Infect Dis Rep       Date:  2017-06       Impact factor: 3.725

2.  Evaluation of 16S rRNA qPCR for detection of Mycobacterium leprae DNA in nasal secretion and skin biopsy samples from multibacillary and paucibacillary leprosy cases.

Authors:  Lívia Érika Carlos Marques; Cristiane Cunha Frota; Josiane da Silva Quetz; Alexandre Havt Bindá; Rosa Maria Salane Mota; Maria Araci de Andrade Pontes; Heitor de Sá Gonçalves; Carl Kendall; Ligia Regina Franco Sansigolo Kerr
Journal:  Pathog Glob Health       Date:  2017-12-26       Impact factor: 2.894

3.  Development of a novel loop-mediated isothermal amplification assay for rapid detection of Mycobacterium leprae in clinical samples.

Authors:  Shweta Joshi; Vanila Sharma; V Ramesh; Ruchi Singh; Poonam Salotra
Journal:  Indian J Dermatol Venereol Leprol       Date:  2021-03-02       Impact factor: 2.545

4.  Latent leprosy infection identified by dual RLEP and anti-PGL-I positivity: Implications for new control strategies.

Authors:  Moises Batista da Silva; Wei Li; Raquel Carvalho Bouth; Angélica Rita Gobbo; Ana Caroline Cunha Messias; Tania Mara Pires Moraes; Erika Vanessa Oliveira Jorge; Josafá Gonçalves Barreto; Fred Bernardes Filho; Guilherme Augusto Barros Conde; Marco Andrey Cipriani Frade; Claudio Guedes Salgado; John Stewart Spencer
Journal:  PLoS One       Date:  2021-05-13       Impact factor: 3.240

5.  Development of a Loop-mediated isothermal amplification (LAMP) technique for specific and early detection of Mycobacterium leprae in clinical samples.

Authors:  Nupur Garg; Upasana Sahu; Sudeshna Kar; Farhan J Ahmad
Journal:  Sci Rep       Date:  2021-05-10       Impact factor: 4.379

6.  A novel integrated molecular and serological analysis method to predict new cases of leprosy amongst household contacts.

Authors:  Rafael Silva Gama; Márcio Luís Moreira de Souza; Euzenir Nunes Sarno; Milton Ozório de Moraes; Aline Gonçalves; Mariane M A Stefani; Raúl Marcel González Garcia; Lucia Alves de Oliveira Fraga
Journal:  PLoS Negl Trop Dis       Date:  2019-06-10

7.  Develop and Field Evolution of Single Tube Nested PCR, SYBRGreen PCR Methods, for the Diagnosis of Leprosy in Paraffin-embedded Formalin Fixed Tissues in Yunnan Province, a Hyper endemic Area of Leprosy in China.

Authors:  Xiaohua Chen; Yan Xing; Jun He; Fuyue Tan; Yuangang You; Yan Wen
Journal:  PLoS Negl Trop Dis       Date:  2019-10-02

8.  Prospects for new leprosy diagnostic tools, a narrative review considering ELISA and PCR assays.

Authors:  Rafael Silva Gama; Lázaro Azevedo Leite; Lívia Tavares Colombo; Lúcia Alves de Oliveira Fraga
Journal:  Rev Soc Bras Med Trop       Date:  2020-11-25       Impact factor: 1.581

9.  Development of a novel loop-mediated isothermal amplification assay for rapid detection of Mycobacterium leprae in clinical samples.

Authors:  Shweta Joshi; Vanila Sharma; V Ramesh; Ruchi Singh; Poonam Salotra
Journal:  Indian J Dermatol Venereol Leprol       Date:  2021 [SEASON]       Impact factor: 2.545

10.  High frequency of M. leprae DNA detection in asymptomatic household contacts.

Authors:  Rafael Silva Gama; Thalisson Artur Ribeiro Gomides; Chaiana Fróes Magalhães Gama; Suelen Justo Maria Moreira; Fernanda Saloum de Neves Manta; Lorena Bruna P de Oliveira; Pedro Henrique Ferreira Marçal; Euzenir Nunes Sarno; Milton Ozório Moraes; Raúl Marcel González Garcia; Lucia Alves de Oliveira Fraga
Journal:  BMC Infect Dis       Date:  2018-04-02       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.